Sol Atriyal Apendikste Trombüsü Olan Hastalarda Perkütan Sol Atriyal Apendiks Kapama

Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893‐2962. doi: 10.1093/eurheartj/ehw210.

January CT, Wann LS, Alpert JS, et al.2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: Executive summary. Circulation. 2014;130(130):2071‐2104. doi: 10.1161/CIR.0000000000000040.

Niku, A.D.; Shiota, T.; Siegel, R.J.; et al. Prevalence and Resolution of Left Atrial Thrombus in Patients with Nonvalvular Atrial Fibrillation and Flutter with Oral Anticoagulation. Am. J. Cardiol. 2019, 123, 63–68. doi: 10.1016/j.amjcard.2018.09.027.

Leung DY, Davidson PM, Cranney GB, et al. Thromboembolic risks of left atrial thrombus detected by transesophageal echocardiogram. Am J Cardiol. 1997;79:626‐629. doi: 10.1016/s0002-9149(96)00828-4.

Karwowski J, Rekosz J, Mączyńska-Mazuruk R, Wiktorska A, Wrzosek K, Loska W, Szmarowska K, Solecki M, Sumińska-Syska J, Dłużniewski M. Left atrial appendage thrombus in patients with atrial fibrillation who underwent oral anticoagulation. Cardiol J. 2024;31(3):461-471. doi: 10.5603/CJ.a2022.0054. Epub 2022 Jun 15. PMID: 35703043; PMCID: PMC11229796.

Zoppo F, Brandolino G, Berton A, et al. Predictors of left atrium appendage clot detection despite on-target warfarin prevention for atrial fibrillation. J Interv Card Electrophysiol. 2012;35(2):151–158. doi: 10.1007/s10840-012-9707-0.

Angelini F, Bocchino PP, Peyracchia M, et al. Prevalence and predictors of left atrial thrombosis in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants. Acta Cardiol 2021. https://doi.org/10.1080/000 15385.2021.2005307; PMID: 34821203; online ahead of press

Bertaglia E, Anselmino M, Zorzi A, et al. NOACs and atrial fibrillation: incidence and predictors of left atrial thrombus in the real world. Int J Cardiol 2017;249:179–83. https://doi. org/10.1016/j.ijcard.2017.07.048; PMID: 29121724.

Farkowski MM, Jubele K, Marín F, et al. Diagnosis and management of left atrial appendage thrombus in patients with atrial fibrillation undergoing cardioversion or percutaneous left atrial procedures: results of the European Heart Rhythm Association survey. Europace 2019;22:162–9.

Harada M, Koshikawa M, Motoike Y, et al. Left atrial appendage thrombus prior to atrial fibrillation ablation in the era of direct oral anticoagulants. Circ J 2018;82:2715–21. https://doi.org/10.1253/circj.CJ-18-0398; PMID: 30101809. 22.Watanabe T, Shinoda Y, Ikeoka K, et al. Dabigatran therapy resulting in the resolution of Rivaroxaban-resistant left atrial appendage thrombi in patients with atrial fibrillation. Intern Med 2017;56:1977–80. https://doi.org/10.2169/ internalmedicine.56.8508; PMID: 28768967

11.Watanabe T, Shinoda Y, Ikeoka K, et al. Dabigatran therapy resulting in the resolution of Rivaroxaban-resistant left atrial appendage thrombi in patients with atrial fibrillation. Intern Med 2017;56:1977–80. https://doi.org/10.2169/ internalmedicine.56.8508; PMID: 28768967

Kołakowski K, Farkowski MM, Pytkowski M, et al. The comparative effectiveness and safety of different anticoagulation strategies for treatment of left atrial appendage thrombus in the setting of chronic anticoagulation for atrial fibrillation or flutter. Cardiovasc Drugs Ther 2023;37:159-68. https://doi.org/10.1007/s10557- 021-07278-9; PMID: 34669102.

Glikson, M.; Wolff, R.; Hindricks, G.; et al. EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion—An update. Europace 2019, 22, 184.

Pak, H.-N.; Shim, C.Y.; Kim, J.-S.; et al. Self-Expandable Device for Percutaneous Closing of Left Atrial Appendage with Organized Thrombus in a Patient with Permanent Atrial Fibrillation. Can. J. Cardiol. 2013, 29, 1329.e1–1329.e3. doi: 10.1016/j.cjca.2012.09.016.

Bellmann, B.; Rillig, A.; Leistner, D.M.; et al. Left atrial appendage closure in a patient with left atrial appendage thrombus using a novel fish ball technique. Int. J. Cardiol. 2017, 234, 146–149. doi: 10.1016/j.ijcard.2016.12.141.

Kaczmarek K, Cygankiewicz I, Streb W, et al. Percutaneous Occlusion of the Left Atrial Appendage with Thrombus Irresponsive to Antithrombotic Therapy. J Clin Med. 2021 Feb 12;10(4):726. doi: 10.3390/jcm10040726. PMID: 33673147; PMCID: PMC7918449. doi: 10.3390/jcm10040726.

Tarantini G, D’Amico G, Latib A, et al. Percutaneous left atrial appendage occlusion in patients with atrial fibrillation and left appendage thrombus: feasibility, safety and clinical efficacy. Euro- Intervention. 2018;13:1595‐1602. doi: 10.4244/EIJ-D-17-00777.

Bordignon S, Bologna F, Chen S, et al. Percutaneous left atrial appendage closure in the presence of thrombus: A feasibility report. J Cardiovasc Electrophysiol. 2019 Dec;30(12):2858-2863. doi: 10.1111/jce.14246. Epub 2019 Oct 31. PMID: 31638713. doi: 10.1111/jce.14246.

Mohandes, M.; Pernigotti, A.; Morr, C.I.; et al. Percutaneous Left Atrial Appendage Closure in the Presence of Thrombus Using LAmbre Device and Cerebral Protection System. Korean Circ. J. 2020, 50, 281–283. doi: 10.4070/kcj.2019.0305.

Tan BE, Depta JP. Transcatheter cerebral embolic protection during WATCHMAN procedure in two patients with persistent left atrial appendage thrombus: Case report with review of the literature. Catheter Cardiovasc Interv. 2021 Feb 1;97(2):365-368. doi: 10.1002/ccd.29060. Epub 2020 Jun 15.

Beneduce A, Ancona F, Marzi A, et al. Percutaneous treatment of persistent left atrial appendage thrombus using watchman FLX no-touch implantation technique and cerebral protection system. JACC: Clin Electrophysiol. 2019;5(10):1231-1232.doi: 10.1016/j.jacep.2019.06.015.

Pandey, A.C.; Smith, M.R.; Olson, N.; Price, M.J.; Gibson, D.N. When Smoke does not always Mean There is Fire. JACC Clin. Electrophysiol. 2019, 5, 136–137. doi: 10.1016/j.jacep.2018.09.018.

Enomoto, Y.; Hara, H.; Makino, K.; Nakamura, K.; Sugi, K.; Moroi, M.; Nakamura, M. Usefulness of an Isoproterenol infusion to differentiate a Left Atrial Appendage Thrombus in a patient with non-valvular atrial fibrillation. Pacing Clin. Electrophysiol. 2020. doi: 10.1111/pace.14033.

Osman M, Busu T, Osman K, et al. Short-term antiplatelet versus anticoagulant therapy after left atrial appendage occlusion a systematic review and meta-analysis. JACC Clin Electrophysiol 2020;6:494–506. https://doi.org/10.1016/j. jacep.2019.11.009; PMID: 32439033.

Litwinowicz R, Filip G, Sobczyk D, et al. Long-term effect of anticoagulation following left atrial appendage occlusion with the LARIAT device in patients with nonvalvular atrial fibrillation: impact on thromboembolism, bleeding and mortality. Real-life data. Postepy Kardiol Interwencyjnej 2020;16:89–96. https://doi.org/10.5114/aic.2020.93916; PMID: 32368241.